Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 12.35
-0.44 (-3.44%)
May 18, 2026, 4:11 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 1.56 billion as of May 18, 2026. Its market cap has increased by 2.59% in one year.
Market Cap
1.56B
Enterprise Value
1.26B
Revenue
64.65M
Ranking
n/a
PE Ratio
53.07
Stock Price
12.35
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.56B, an increase of 7,355.12%. That is a compound annual growth rate of 22.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 1.56B | -33.80% |
| Dec 31, 2025 | 2.36B | 48.44% |
| Dec 31, 2024 | 1.59B | -50.04% |
| Dec 29, 2023 | 3.18B | 217.33% |
| Dec 30, 2022 | 1.00B | 110.88% |
| Dec 31, 2021 | 474.89M | 222.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.99B |
| Mesoblast | 2.73B |
| PYC Therapeutics | 1.41B |
| Clarity Pharmaceuticals | 1.08B |
| Opthea | 738.77M |
| Racura Oncology | 516.39M |
| Clinuvel Pharmaceuticals | 477.55M |
| Starpharma Holdings | 261.11M |